nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—hypertension—obesity	0.432	1	CtDrD
Hydralazine—AOC3—obesity	0.36	1	CbGaD
Hydralazine—CYP3A4—Sibutramine—obesity	0.0202	0.27	CbGbCtD
Hydralazine—CYP3A4—Benzphetamine—obesity	0.0153	0.204	CbGbCtD
Hydralazine—CYP3A4—Bupropion—obesity	0.013	0.174	CbGbCtD
Hydralazine—CYP3A4—Orlistat—obesity	0.0106	0.142	CbGbCtD
Hydralazine—CYP3A4—Cimetidine—obesity	0.00957	0.127	CbGbCtD
Hydralazine—AOC3—brown adipose tissue—obesity	0.00696	0.198	CbGeAlD
Hydralazine—CYP3A4—Topiramate—obesity	0.00627	0.0834	CbGbCtD
Hydralazine—RYR2—hindbrain—obesity	0.00378	0.108	CbGeAlD
Hydralazine—RYR2—adrenal cortex—obesity	0.00194	0.0552	CbGeAlD
Hydralazine—RYR2—cardiovascular system—obesity	0.00177	0.0504	CbGeAlD
Hydralazine—RYR2—pituitary gland—obesity	0.00157	0.0446	CbGeAlD
Hydralazine—RYR2—adrenal gland—obesity	0.0014	0.0399	CbGeAlD
Hydralazine—AOC3—respiratory system—obesity	0.00139	0.0396	CbGeAlD
Hydralazine—RYR2—endocrine gland—obesity	0.00121	0.0346	CbGeAlD
Hydralazine—P4HA1—islet of Langerhans—obesity	0.00118	0.0336	CbGeAlD
Hydralazine—AOC3—adrenal cortex—obesity	0.00117	0.0333	CbGeAlD
Hydralazine—P4HA1—respiratory system—obesity	0.00111	0.0317	CbGeAlD
Hydralazine—AOC3—cardiovascular system—obesity	0.00106	0.0304	CbGeAlD
Hydralazine—AOC3—pituitary gland—obesity	0.000943	0.0269	CbGeAlD
Hydralazine—AOC3—adipose tissue—obesity	0.000939	0.0268	CbGeAlD
Hydralazine—P4HA1—adrenal cortex—obesity	0.000933	0.0266	CbGeAlD
Hydralazine—AOC3—digestive system—obesity	0.000884	0.0252	CbGeAlD
Hydralazine—P4HA1—cardiovascular system—obesity	0.000851	0.0243	CbGeAlD
Hydralazine—AOC3—adrenal gland—obesity	0.000842	0.024	CbGeAlD
Hydralazine—P4HA1—pituitary gland—obesity	0.000754	0.0215	CbGeAlD
Hydralazine—P4HA1—adipose tissue—obesity	0.000751	0.0214	CbGeAlD
Hydralazine—AOC3—endocrine gland—obesity	0.00073	0.0208	CbGeAlD
Hydralazine—P4HA1—adrenal gland—obesity	0.000673	0.0192	CbGeAlD
Hydralazine—AOC3—liver—obesity	0.000659	0.0188	CbGeAlD
Hydralazine—P4HA1—endocrine gland—obesity	0.000584	0.0166	CbGeAlD
Hydralazine—P4HA1—liver—obesity	0.000527	0.015	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CPT1A—obesity	0.000348	0.0135	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—AQP7—obesity	0.000347	0.0135	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IGFBP3—obesity	0.000341	0.0132	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GCK—obesity	0.000339	0.0132	CbGpPWpGaD
Hydralazine—CYP3A4—Irinotecan Pathway—CES1—obesity	0.00033	0.0128	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CRH—obesity	0.000329	0.0128	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TF—obesity	0.000323	0.0126	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC16A7—obesity	0.000317	0.0123	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB1—obesity	0.000305	0.0119	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000304	0.0118	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NTRK2—obesity	0.000296	0.0115	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—LCN2—obesity	0.000295	0.0115	CbGpPWpGaD
Hydralazine—CYP3A4—Liver X Receptor Pathway—SCD—obesity	0.000278	0.0108	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—COX7C—obesity	0.000277	0.0108	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—ESR2—obesity	0.000273	0.0106	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS1—obesity	0.000272	0.0106	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—FTL—obesity	0.000251	0.00976	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GABRA6—obesity	0.000251	0.00976	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB2—obesity	0.000247	0.00962	CbGpPWpGaD
Hydralazine—Hepatic function abnormal—Bupropion—obesity	0.000247	0.00339	CcSEcCtD
Hydralazine—Discomfort—Diethylpropion—obesity	0.000246	0.00339	CcSEcCtD
Hydralazine—Constipation—Phenylpropanolamine—obesity	0.000246	0.00338	CcSEcCtD
Hydralazine—Dizziness—Benzphetamine—obesity	0.000244	0.00335	CcSEcCtD
Hydralazine—Dyspepsia—Phentermine—obesity	0.000242	0.00333	CcSEcCtD
Hydralazine—Psychotic disorder—Sibutramine—obesity	0.000241	0.00332	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—AR—obesity	0.000241	0.00938	CbGpPWpGaD
Hydralazine—Disorientation—Bupropion—obesity	0.000241	0.00331	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC6A14—obesity	0.00024	0.00935	CbGpPWpGaD
Hydralazine—Headache—Methamphetamine—obesity	0.00024	0.00329	CcSEcCtD
Hydralazine—Arthralgia—Cimetidine—obesity	0.000237	0.00326	CcSEcCtD
Hydralazine—Myalgia—Cimetidine—obesity	0.000237	0.00326	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Phentermine—obesity	0.000237	0.00326	CcSEcCtD
Hydralazine—Nasal congestion—Bupropion—obesity	0.000237	0.00325	CcSEcCtD
Hydralazine—Feeling abnormal—Phenylpropanolamine—obesity	0.000237	0.00325	CcSEcCtD
Hydralazine—Anxiety—Cimetidine—obesity	0.000236	0.00325	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GNB3—obesity	0.000236	0.00917	CbGpPWpGaD
Hydralazine—Urinary retention—Sibutramine—obesity	0.000235	0.00323	CcSEcCtD
Hydralazine—Constipation—Phentermine—obesity	0.000235	0.00323	CcSEcCtD
Hydralazine—Tachycardia—Diethylpropion—obesity	0.000233	0.00321	CcSEcCtD
Hydralazine—Headache—Benzphetamine—obesity	0.000231	0.00318	CcSEcCtD
Hydralazine—Cramp muscle—Orlistat—obesity	0.00023	0.00316	CcSEcCtD
Hydralazine—Diarrhoea—Phendimetrazine—obesity	0.00023	0.00316	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GNAS—obesity	0.000229	0.00892	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GNB3—obesity	0.000228	0.00888	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000227	0.00883	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GNB3—obesity	0.000227	0.00883	CbGpPWpGaD
Hydralazine—Thrombocytopenia—Cimetidine—obesity	0.000223	0.00306	CcSEcCtD
Hydralazine—Dizziness—Phendimetrazine—obesity	0.000222	0.00306	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GNAS—obesity	0.000222	0.00865	CbGpPWpGaD
Hydralazine—Tachycardia—Cimetidine—obesity	0.000222	0.00305	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—BDNF—obesity	0.000221	0.00858	CbGpPWpGaD
Hydralazine—Nausea—Benzphetamine—obesity	0.000219	0.00301	CcSEcCtD
Hydralazine—Sensory loss—Topiramate—obesity	0.000218	0.003	CcSEcCtD
Hydralazine—Urticaria—Phentermine—obesity	0.000218	0.003	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000218	0.00299	CcSEcCtD
Hydralazine—Dyspnoea—Diethylpropion—obesity	0.000213	0.00293	CcSEcCtD
Hydralazine—Eosinophilia—Sibutramine—obesity	0.000212	0.00291	CcSEcCtD
Hydralazine—Hypersensitivity—Phenylpropanolamine—obesity	0.000212	0.00291	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL10—obesity	0.000211	0.00819	CbGpPWpGaD
Hydralazine—Headache—Phendimetrazine—obesity	0.000211	0.0029	CcSEcCtD
Hydralazine—Psychotic disorder—Bupropion—obesity	0.00021	0.00289	CcSEcCtD
Hydralazine—Dyspepsia—Diethylpropion—obesity	0.00021	0.00289	CcSEcCtD
Hydralazine—Angina pectoris—Sibutramine—obesity	0.000208	0.00286	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Cimetidine—obesity	0.000207	0.00285	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Diethylpropion—obesity	0.000206	0.00284	CcSEcCtD
Hydralazine—Lacrimation increased—Topiramate—obesity	0.000205	0.00282	CcSEcCtD
Hydralazine—Urinary retention—Bupropion—obesity	0.000205	0.00282	CcSEcCtD
Hydralazine—Constipation—Diethylpropion—obesity	0.000204	0.00281	CcSEcCtD
Hydralazine—Dysuria—Sibutramine—obesity	0.0002	0.00275	CcSEcCtD
Hydralazine—Nausea—Phendimetrazine—obesity	0.0002	0.00275	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC9A3—obesity	0.000199	0.00775	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCD—obesity	0.000198	0.00769	CbGpPWpGaD
Hydralazine—Feeling abnormal—Diethylpropion—obesity	0.000197	0.00271	CcSEcCtD
Hydralazine—Depression—Orlistat—obesity	0.000196	0.0027	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NR3C1—obesity	0.000195	0.00758	CbGpPWpGaD
Hydralazine—Constipation—Cimetidine—obesity	0.000194	0.00267	CcSEcCtD
Hydralazine—Cramp muscle—Bupropion—obesity	0.000194	0.00267	CcSEcCtD
Hydralazine—Neuropathy peripheral—Orlistat—obesity	0.000193	0.00265	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCD—obesity	0.000191	0.00745	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HK2—obesity	0.00019	0.00739	CbGpPWpGaD
Hydralazine—Depression—Sibutramine—obesity	0.00019	0.00261	CcSEcCtD
Hydralazine—Urticaria—Diethylpropion—obesity	0.00019	0.00261	CcSEcCtD
Hydralazine—Dizziness—Phenylpropanolamine—obesity	0.00019	0.00261	CcSEcCtD
Hydralazine—Diarrhoea—Phentermine—obesity	0.000188	0.00259	CcSEcCtD
Hydralazine—Feeling abnormal—Cimetidine—obesity	0.000187	0.00258	CcSEcCtD
Hydralazine—CYP3A4—digestive system—obesity	0.000187	0.00534	CbGeAlD
Hydralazine—Neuropathy peripheral—Sibutramine—obesity	0.000187	0.00257	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HTR2A—obesity	0.000186	0.00725	CbGpPWpGaD
Hydralazine—Conjunctivitis—Sibutramine—obesity	0.000185	0.00255	CcSEcCtD
Hydralazine—Vomiting—Phenylpropanolamine—obesity	0.000183	0.00251	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC27A1—obesity	0.000182	0.00709	CbGpPWpGaD
Hydralazine—Dizziness—Phentermine—obesity	0.000182	0.0025	CcSEcCtD
Hydralazine—Haematuria—Sibutramine—obesity	0.000182	0.0025	CcSEcCtD
Hydralazine—Rash—Phenylpropanolamine—obesity	0.000181	0.00249	CcSEcCtD
Hydralazine—Dermatitis—Phenylpropanolamine—obesity	0.000181	0.00249	CcSEcCtD
Hydralazine—Body temperature increased—Cimetidine—obesity	0.00018	0.00247	CcSEcCtD
Hydralazine—Pancytopenia—Bupropion—obesity	0.000177	0.00243	CcSEcCtD
Hydralazine—Hepatitis—Orlistat—obesity	0.000177	0.00243	CcSEcCtD
Hydralazine—Vomiting—Phentermine—obesity	0.000175	0.0024	CcSEcCtD
Hydralazine—Dysuria—Bupropion—obesity	0.000174	0.0024	CcSEcCtD
Hydralazine—Rash—Phentermine—obesity	0.000173	0.00238	CcSEcCtD
Hydralazine—Dermatitis—Phentermine—obesity	0.000173	0.00238	CcSEcCtD
Hydralazine—Headache—Phentermine—obesity	0.000172	0.00237	CcSEcCtD
Hydralazine—Nausea—Phenylpropanolamine—obesity	0.000171	0.00235	CcSEcCtD
Hydralazine—Hypoaesthesia—Sibutramine—obesity	0.00017	0.00234	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCB—obesity	0.00017	0.0066	CbGpPWpGaD
Hydralazine—Weight decreased—Bupropion—obesity	0.000169	0.00232	CcSEcCtD
Hydralazine—Hypersensitivity—Cimetidine—obesity	0.000168	0.0023	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCB—obesity	0.000164	0.00639	CbGpPWpGaD
Hydralazine—Diarrhoea—Diethylpropion—obesity	0.000164	0.00225	CcSEcCtD
Hydralazine—Nausea—Phentermine—obesity	0.000163	0.00224	CcSEcCtD
Hydralazine—Neuropathy peripheral—Bupropion—obesity	0.000163	0.00224	CcSEcCtD
Hydralazine—Jaundice—Bupropion—obesity	0.000162	0.00223	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—STS—obesity	0.000162	0.00629	CbGpPWpGaD
Hydralazine—Conjunctivitis—Bupropion—obesity	0.000161	0.00222	CcSEcCtD
Hydralazine—Lymphadenopathy—Topiramate—obesity	0.000161	0.00221	CcSEcCtD
Hydralazine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.000159	0.00619	CbGpPWpGaD
Hydralazine—Dizziness—Diethylpropion—obesity	0.000158	0.00217	CcSEcCtD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000156	0.00606	CbGpPWpGaD
Hydralazine—Diarrhoea—Cimetidine—obesity	0.000156	0.00214	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—TRPV1—obesity	0.000155	0.00603	CbGpPWpGaD
Hydralazine—CYP3A4—endocrine gland—obesity	0.000155	0.00441	CbGeAlD
Hydralazine—Disorientation—Topiramate—obesity	0.000153	0.00211	CcSEcCtD
Hydralazine—Vascular purpura—Topiramate—obesity	0.000153	0.00211	CcSEcCtD
Hydralazine—Chills—Sibutramine—obesity	0.000153	0.00211	CcSEcCtD
Hydralazine—Vomiting—Diethylpropion—obesity	0.000152	0.00209	CcSEcCtD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.000151	0.00587	CbGpPWpGaD
Hydralazine—Nasal congestion—Topiramate—obesity	0.000151	0.00207	CcSEcCtD
Hydralazine—Rash—Diethylpropion—obesity	0.000151	0.00207	CcSEcCtD
Hydralazine—Dermatitis—Diethylpropion—obesity	0.000151	0.00207	CcSEcCtD
Hydralazine—Dizziness—Cimetidine—obesity	0.00015	0.00207	CcSEcCtD
Hydralazine—Headache—Diethylpropion—obesity	0.00015	0.00206	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—HK1—obesity	0.000149	0.0058	CbGpPWpGaD
Hydralazine—Hepatitis—Bupropion—obesity	0.000149	0.00205	CcSEcCtD
Hydralazine—Hallucination—Bupropion—obesity	0.000148	0.00204	CcSEcCtD
Hydralazine—Hypoaesthesia—Bupropion—obesity	0.000148	0.00204	CcSEcCtD
Hydralazine—Muscle spasms—Orlistat—obesity	0.000148	0.00203	CcSEcCtD
Hydralazine—Vomiting—Cimetidine—obesity	0.000145	0.00199	CcSEcCtD
Hydralazine—Rash—Cimetidine—obesity	0.000143	0.00197	CcSEcCtD
Hydralazine—Dermatitis—Cimetidine—obesity	0.000143	0.00197	CcSEcCtD
Hydralazine—Muscle spasms—Sibutramine—obesity	0.000143	0.00197	CcSEcCtD
Hydralazine—Ill-defined disorder—Orlistat—obesity	0.000143	0.00196	CcSEcCtD
Hydralazine—Headache—Cimetidine—obesity	0.000142	0.00196	CcSEcCtD
Hydralazine—Purpura—Topiramate—obesity	0.000142	0.00196	CcSEcCtD
Hydralazine—Nausea—Diethylpropion—obesity	0.000142	0.00195	CcSEcCtD
Hydralazine—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.00014	0.00544	CbGpPWpGaD
Hydralazine—CYP3A4—liver—obesity	0.00014	0.00398	CbGeAlD
Hydralazine—Tremor—Sibutramine—obesity	0.000139	0.00192	CcSEcCtD
Hydralazine—Malaise—Orlistat—obesity	0.000139	0.00191	CcSEcCtD
Hydralazine—Flushing—Bupropion—obesity	0.000138	0.0019	CcSEcCtD
Hydralazine—Ill-defined disorder—Sibutramine—obesity	0.000138	0.0019	CcSEcCtD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000138	0.00537	CbGpPWpGaD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000138	0.00537	CbGpPWpGaD
Hydralazine—Anaemia—Sibutramine—obesity	0.000138	0.00189	CcSEcCtD
Hydralazine—Agitation—Sibutramine—obesity	0.000137	0.00188	CcSEcCtD
Hydralazine—Palpitations—Orlistat—obesity	0.000136	0.00187	CcSEcCtD
Hydralazine—Nausea—Cimetidine—obesity	0.000135	0.00186	CcSEcCtD
Hydralazine—Malaise—Sibutramine—obesity	0.000134	0.00185	CcSEcCtD
Hydralazine—Psychotic disorder—Topiramate—obesity	0.000134	0.00184	CcSEcCtD
Hydralazine—Chills—Bupropion—obesity	0.000134	0.00184	CcSEcCtD
Hydralazine—Leukopenia—Sibutramine—obesity	0.000133	0.00183	CcSEcCtD
Hydralazine—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000133	0.00518	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC22A1—obesity	0.000132	0.00512	CbGpPWpGaD
Hydralazine—Palpitations—Sibutramine—obesity	0.000132	0.00181	CcSEcCtD
Hydralazine—Myalgia—Orlistat—obesity	0.000131	0.0018	CcSEcCtD
Hydralazine—Urinary retention—Topiramate—obesity	0.000131	0.0018	CcSEcCtD
Hydralazine—Anxiety—Orlistat—obesity	0.000131	0.0018	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS3—obesity	0.00013	0.00508	CbGpPWpGaD
Hydralazine—Discomfort—Orlistat—obesity	0.000129	0.00178	CcSEcCtD
Hydralazine—Myalgia—Sibutramine—obesity	0.000127	0.00174	CcSEcCtD
Hydralazine—Arthralgia—Sibutramine—obesity	0.000127	0.00174	CcSEcCtD
Hydralazine—Anxiety—Sibutramine—obesity	0.000126	0.00174	CcSEcCtD
Hydralazine—Oedema—Orlistat—obesity	0.000126	0.00173	CcSEcCtD
Hydralazine—Discomfort—Sibutramine—obesity	0.000125	0.00172	CcSEcCtD
Hydralazine—Muscle spasms—Bupropion—obesity	0.000125	0.00172	CcSEcCtD
Hydralazine—Tremor—Bupropion—obesity	0.000122	0.00167	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—PRKAR2B—obesity	0.000122	0.00473	CbGpPWpGaD
Hydralazine—Oedema—Sibutramine—obesity	0.000122	0.00167	CcSEcCtD
Hydralazine—Ill-defined disorder—Bupropion—obesity	0.00012	0.00166	CcSEcCtD
Hydralazine—Anaemia—Bupropion—obesity	0.00012	0.00165	CcSEcCtD
Hydralazine—Agitation—Bupropion—obesity	0.000119	0.00164	CcSEcCtD
Hydralazine—Thrombocytopenia—Sibutramine—obesity	0.000119	0.00164	CcSEcCtD
Hydralazine—Tachycardia—Sibutramine—obesity	0.000119	0.00163	CcSEcCtD
Hydralazine—Eosinophilia—Topiramate—obesity	0.000118	0.00162	CcSEcCtD
Hydralazine—Malaise—Bupropion—obesity	0.000117	0.00161	CcSEcCtD
Hydralazine—Leukopenia—Bupropion—obesity	0.000116	0.0016	CcSEcCtD
Hydralazine—Anorexia—Sibutramine—obesity	0.000116	0.00159	CcSEcCtD
Hydralazine—Angina pectoris—Topiramate—obesity	0.000116	0.00159	CcSEcCtD
Hydralazine—Palpitations—Bupropion—obesity	0.000115	0.00158	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—GCK—obesity	0.000114	0.00445	CbGpPWpGaD
Hydralazine—Musculoskeletal discomfort—Orlistat—obesity	0.000114	0.00157	CcSEcCtD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000114	0.00445	CbGpPWpGaD
Hydralazine—Hypotension—Sibutramine—obesity	0.000114	0.00156	CcSEcCtD
Hydralazine—Paraesthesia—Orlistat—obesity	0.000113	0.00155	CcSEcCtD
Hydralazine—Pancytopenia—Topiramate—obesity	0.000113	0.00155	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—obesity	0.000111	0.00432	CbGpPWpGaD
Hydralazine—Dysuria—Topiramate—obesity	0.000111	0.00153	CcSEcCtD
Hydralazine—Neutropenia—Topiramate—obesity	0.000111	0.00153	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Sibutramine—obesity	0.000111	0.00152	CcSEcCtD
Hydralazine—Dyspepsia—Orlistat—obesity	0.000111	0.00152	CcSEcCtD
Hydralazine—Arthralgia—Bupropion—obesity	0.00011	0.00152	CcSEcCtD
Hydralazine—Myalgia—Bupropion—obesity	0.00011	0.00152	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—obesity	0.00011	0.0043	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CETP—obesity	0.00011	0.00429	CbGpPWpGaD
Hydralazine—Anxiety—Bupropion—obesity	0.00011	0.00151	CcSEcCtD
Hydralazine—Discomfort—Bupropion—obesity	0.000109	0.0015	CcSEcCtD
Hydralazine—Decreased appetite—Orlistat—obesity	0.000109	0.0015	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—TF—obesity	0.000109	0.00425	CbGpPWpGaD
Hydralazine—Paraesthesia—Sibutramine—obesity	0.000109	0.0015	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Orlistat—obesity	0.000108	0.00149	CcSEcCtD
Hydralazine—Dyspnoea—Sibutramine—obesity	0.000108	0.00149	CcSEcCtD
Hydralazine—Weight decreased—Topiramate—obesity	0.000107	0.00148	CcSEcCtD
Hydralazine—Dyspepsia—Sibutramine—obesity	0.000107	0.00147	CcSEcCtD
Hydralazine—Oedema—Bupropion—obesity	0.000106	0.00146	CcSEcCtD
Hydralazine—Decreased appetite—Sibutramine—obesity	0.000106	0.00145	CcSEcCtD
Hydralazine—Depression—Topiramate—obesity	0.000106	0.00145	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Sibutramine—obesity	0.000105	0.00144	CcSEcCtD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000105	0.00407	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TFRC—obesity	0.000105	0.00407	CbGpPWpGaD
Hydralazine—Constipation—Sibutramine—obesity	0.000104	0.00143	CcSEcCtD
Hydralazine—Neuropathy peripheral—Topiramate—obesity	0.000104	0.00143	CcSEcCtD
Hydralazine—Thrombocytopenia—Bupropion—obesity	0.000104	0.00143	CcSEcCtD
Hydralazine—Feeling abnormal—Orlistat—obesity	0.000103	0.00142	CcSEcCtD
Hydralazine—Tachycardia—Bupropion—obesity	0.000103	0.00142	CcSEcCtD
Hydralazine—Conjunctivitis—Topiramate—obesity	0.000103	0.00141	CcSEcCtD
Hydralazine—CYP3A4—Irinotecan Pathway—BCHE—obesity	0.000101	0.00394	CbGpPWpGaD
Hydralazine—Anorexia—Bupropion—obesity	0.000101	0.00139	CcSEcCtD
Hydralazine—Haematuria—Topiramate—obesity	0.000101	0.00139	CcSEcCtD
Hydralazine—Feeling abnormal—Sibutramine—obesity	0.0001	0.00138	CcSEcCtD
Hydralazine—Urticaria—Orlistat—obesity	9.97e-05	0.00137	CcSEcCtD
Hydralazine—Body temperature increased—Orlistat—obesity	9.93e-05	0.00137	CcSEcCtD
Hydralazine—Hypotension—Bupropion—obesity	9.9e-05	0.00136	CcSEcCtD
Hydralazine—Agranulocytosis—Topiramate—obesity	9.87e-05	0.00136	CcSEcCtD
Hydralazine—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	9.66e-05	0.00376	CbGpPWpGaD
Hydralazine—Urticaria—Sibutramine—obesity	9.65e-05	0.00133	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Bupropion—obesity	9.65e-05	0.00133	CcSEcCtD
Hydralazine—Body temperature increased—Sibutramine—obesity	9.61e-05	0.00132	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	9.52e-05	0.0037	CbGpPWpGaD
Hydralazine—Paraesthesia—Bupropion—obesity	9.51e-05	0.00131	CcSEcCtD
Hydralazine—Hepatitis—Topiramate—obesity	9.5e-05	0.00131	CcSEcCtD
Hydralazine—Hypoaesthesia—Topiramate—obesity	9.45e-05	0.0013	CcSEcCtD
Hydralazine—Hallucination—Topiramate—obesity	9.45e-05	0.0013	CcSEcCtD
Hydralazine—Dyspnoea—Bupropion—obesity	9.44e-05	0.0013	CcSEcCtD
Hydralazine—Dyspepsia—Bupropion—obesity	9.32e-05	0.00128	CcSEcCtD
Hydralazine—Hypersensitivity—Orlistat—obesity	9.25e-05	0.00127	CcSEcCtD
Hydralazine—Decreased appetite—Bupropion—obesity	9.21e-05	0.00127	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Bupropion—obesity	9.15e-05	0.00126	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	9.1e-05	0.00354	CbGpPWpGaD
Hydralazine—Constipation—Bupropion—obesity	9.06e-05	0.00125	CcSEcCtD
Hydralazine—Hypersensitivity—Sibutramine—obesity	8.95e-05	0.00123	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC2A4—obesity	8.9e-05	0.00346	CbGpPWpGaD
Hydralazine—Pruritus—Orlistat—obesity	8.88e-05	0.00122	CcSEcCtD
Hydralazine—Flushing—Topiramate—obesity	8.82e-05	0.00121	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—CYCS—obesity	8.78e-05	0.00342	CbGpPWpGaD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	8.78e-05	0.00342	CbGpPWpGaD
Hydralazine—Feeling abnormal—Bupropion—obesity	8.73e-05	0.0012	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	8.67e-05	0.00337	CbGpPWpGaD
Hydralazine—Pruritus—Sibutramine—obesity	8.6e-05	0.00118	CcSEcCtD
Hydralazine—Diarrhoea—Orlistat—obesity	8.59e-05	0.00118	CcSEcCtD
Hydralazine—Chills—Topiramate—obesity	8.52e-05	0.00117	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—NCOA1—obesity	8.49e-05	0.0033	CbGpPWpGaD
Hydralazine—Urticaria—Bupropion—obesity	8.42e-05	0.00116	CcSEcCtD
Hydralazine—Body temperature increased—Bupropion—obesity	8.37e-05	0.00115	CcSEcCtD
Hydralazine—Diarrhoea—Sibutramine—obesity	8.31e-05	0.00114	CcSEcCtD
Hydralazine—Dizziness—Orlistat—obesity	8.3e-05	0.00114	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLG—obesity	8.27e-05	0.00322	CbGpPWpGaD
Hydralazine—Dizziness—Sibutramine—obesity	8.04e-05	0.00111	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—obesity	8.02e-05	0.00312	CbGpPWpGaD
Hydralazine—Vomiting—Orlistat—obesity	7.98e-05	0.0011	CcSEcCtD
Hydralazine—Muscle spasms—Topiramate—obesity	7.95e-05	0.00109	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	7.93e-05	0.00308	CbGpPWpGaD
Hydralazine—Rash—Orlistat—obesity	7.92e-05	0.00109	CcSEcCtD
Hydralazine—Dermatitis—Orlistat—obesity	7.91e-05	0.00109	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—NQO1—obesity	7.9e-05	0.00307	CbGpPWpGaD
Hydralazine—Headache—Orlistat—obesity	7.87e-05	0.00108	CcSEcCtD
Hydralazine—Hypersensitivity—Bupropion—obesity	7.8e-05	0.00107	CcSEcCtD
Hydralazine—Tremor—Topiramate—obesity	7.75e-05	0.00107	CcSEcCtD
Hydralazine—Vomiting—Sibutramine—obesity	7.73e-05	0.00106	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	7.71e-05	0.003	CbGpPWpGaD
Hydralazine—Ill-defined disorder—Topiramate—obesity	7.67e-05	0.00106	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—GNB3—obesity	7.67e-05	0.00298	CbGpPWpGaD
Hydralazine—Rash—Sibutramine—obesity	7.66e-05	0.00105	CcSEcCtD
Hydralazine—Dermatitis—Sibutramine—obesity	7.65e-05	0.00105	CcSEcCtD
Hydralazine—Anaemia—Topiramate—obesity	7.64e-05	0.00105	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—obesity	7.63e-05	0.00297	CbGpPWpGaD
Hydralazine—Headache—Sibutramine—obesity	7.61e-05	0.00105	CcSEcCtD
Hydralazine—Agitation—Topiramate—obesity	7.6e-05	0.00105	CcSEcCtD
Hydralazine—Pruritus—Bupropion—obesity	7.49e-05	0.00103	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—GNAS—obesity	7.47e-05	0.0029	CbGpPWpGaD
Hydralazine—Nausea—Orlistat—obesity	7.46e-05	0.00103	CcSEcCtD
Hydralazine—Malaise—Topiramate—obesity	7.46e-05	0.00103	CcSEcCtD
Hydralazine—Leukopenia—Topiramate—obesity	7.4e-05	0.00102	CcSEcCtD
Hydralazine—CYP3A4—Xenobiotics—CYP2E1—obesity	7.34e-05	0.00286	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOB—obesity	7.31e-05	0.00284	CbGpPWpGaD
Hydralazine—Palpitations—Topiramate—obesity	7.31e-05	0.00101	CcSEcCtD
Hydralazine—Diarrhoea—Bupropion—obesity	7.25e-05	0.000997	CcSEcCtD
Hydralazine—Nausea—Sibutramine—obesity	7.22e-05	0.000993	CcSEcCtD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	7.06e-05	0.00275	CbGpPWpGaD
Hydralazine—Myalgia—Topiramate—obesity	7.04e-05	0.000968	CcSEcCtD
Hydralazine—Arthralgia—Topiramate—obesity	7.04e-05	0.000968	CcSEcCtD
Hydralazine—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	7.02e-05	0.00273	CbGpPWpGaD
Hydralazine—Anxiety—Topiramate—obesity	7.02e-05	0.000965	CcSEcCtD
Hydralazine—Dizziness—Bupropion—obesity	7e-05	0.000963	CcSEcCtD
Hydralazine—Discomfort—Topiramate—obesity	6.96e-05	0.000957	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	6.9e-05	0.00268	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—ECHS1—obesity	6.81e-05	0.00265	CbGpPWpGaD
Hydralazine—Oedema—Topiramate—obesity	6.75e-05	0.000928	CcSEcCtD
Hydralazine—Vomiting—Bupropion—obesity	6.74e-05	0.000926	CcSEcCtD
Hydralazine—Rash—Bupropion—obesity	6.68e-05	0.000919	CcSEcCtD
Hydralazine—Dermatitis—Bupropion—obesity	6.67e-05	0.000918	CcSEcCtD
Hydralazine—Headache—Bupropion—obesity	6.64e-05	0.000913	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—COMT—obesity	6.62e-05	0.00258	CbGpPWpGaD
Hydralazine—Thrombocytopenia—Topiramate—obesity	6.61e-05	0.000909	CcSEcCtD
Hydralazine—Tachycardia—Topiramate—obesity	6.59e-05	0.000906	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL6—obesity	6.5e-05	0.00253	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6—obesity	6.47e-05	0.00252	CbGpPWpGaD
Hydralazine—Anorexia—Topiramate—obesity	6.43e-05	0.000885	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—HADH—obesity	6.4e-05	0.00249	CbGpPWpGaD
Hydralazine—Hypotension—Topiramate—obesity	6.31e-05	0.000867	CcSEcCtD
Hydralazine—Nausea—Bupropion—obesity	6.29e-05	0.000865	CcSEcCtD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	6.25e-05	0.00243	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	6.17e-05	0.0024	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PPARA—obesity	6.17e-05	0.0024	CbGpPWpGaD
Hydralazine—Musculoskeletal discomfort—Topiramate—obesity	6.15e-05	0.000846	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	6.09e-05	0.00237	CbGpPWpGaD
Hydralazine—Paraesthesia—Topiramate—obesity	6.06e-05	0.000833	CcSEcCtD
Hydralazine—Dyspnoea—Topiramate—obesity	6.02e-05	0.000828	CcSEcCtD
Hydralazine—Dyspepsia—Topiramate—obesity	5.94e-05	0.000817	CcSEcCtD
Hydralazine—Decreased appetite—Topiramate—obesity	5.87e-05	0.000807	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Topiramate—obesity	5.83e-05	0.000801	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOA1—obesity	5.78e-05	0.00225	CbGpPWpGaD
Hydralazine—Constipation—Topiramate—obesity	5.77e-05	0.000794	CcSEcCtD
Hydralazine—Feeling abnormal—Topiramate—obesity	5.56e-05	0.000765	CcSEcCtD
Hydralazine—Urticaria—Topiramate—obesity	5.36e-05	0.000737	CcSEcCtD
Hydralazine—Body temperature increased—Topiramate—obesity	5.34e-05	0.000734	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	5e-05	0.00195	CbGpPWpGaD
Hydralazine—Hypersensitivity—Topiramate—obesity	4.97e-05	0.000684	CcSEcCtD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	4.87e-05	0.0019	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	4.8e-05	0.00187	CbGpPWpGaD
Hydralazine—Pruritus—Topiramate—obesity	4.77e-05	0.000657	CcSEcCtD
Hydralazine—Diarrhoea—Topiramate—obesity	4.62e-05	0.000635	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ALB—obesity	4.58e-05	0.00178	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	4.56e-05	0.00177	CbGpPWpGaD
Hydralazine—Dizziness—Topiramate—obesity	4.46e-05	0.000614	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	4.39e-05	0.00171	CbGpPWpGaD
Hydralazine—Vomiting—Topiramate—obesity	4.29e-05	0.00059	CcSEcCtD
Hydralazine—Rash—Topiramate—obesity	4.26e-05	0.000585	CcSEcCtD
Hydralazine—Dermatitis—Topiramate—obesity	4.25e-05	0.000585	CcSEcCtD
Hydralazine—Headache—Topiramate—obesity	4.23e-05	0.000581	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	4.12e-05	0.0016	CbGpPWpGaD
Hydralazine—Nausea—Topiramate—obesity	4.01e-05	0.000551	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	3.77e-05	0.00147	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	3.72e-05	0.00145	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	3.36e-05	0.00131	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	3.16e-05	0.00123	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	3.05e-05	0.00119	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	3.01e-05	0.00117	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	2.76e-05	0.00107	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	2.72e-05	0.00106	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	2.68e-05	0.00104	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP26B1—obesity	2.66e-05	0.00103	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	2.62e-05	0.00102	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	2.61e-05	0.00101	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	2.47e-05	0.000962	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—ADH1B—obesity	2.33e-05	0.000907	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	2.24e-05	0.00087	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	2.2e-05	0.000857	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—SULT2A1—obesity	1.8e-05	0.000699	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	1.77e-05	0.000689	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GPX3—obesity	1.69e-05	0.000657	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	1.63e-05	0.000635	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	1.48e-05	0.000576	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	1.32e-05	0.000515	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2E1—obesity	1.31e-05	0.000511	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	1.29e-05	0.000504	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GGT1—obesity	1.21e-05	0.000469	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—NCOA1—obesity	1.19e-05	0.000462	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP19A1—obesity	1.17e-05	0.000455	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	1.15e-05	0.000449	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CA3—obesity	1.09e-05	0.000426	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—COMT—obesity	1.09e-05	0.000423	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—COMT—obesity	1.07e-05	0.000417	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GLRX—obesity	9.31e-06	0.000362	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ETFDH—obesity	8.3e-06	0.000323	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPM1L—obesity	8.3e-06	0.000323	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—OTC—obesity	8.3e-06	0.000323	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—INSIG2—obesity	8.3e-06	0.000323	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UQCRC2—obesity	7.59e-06	0.000295	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—INPP5E—obesity	7.59e-06	0.000295	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPT—obesity	7.59e-06	0.000295	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDH6A1—obesity	7.06e-06	0.000275	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SUCLG2—obesity	7.06e-06	0.000275	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ME1—obesity	7.06e-06	0.000275	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—POMC—obesity	7.03e-06	0.000274	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—COX7C—obesity	6.63e-06	0.000258	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PNPLA3—obesity	6.63e-06	0.000258	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UCP1—obesity	6.63e-06	0.000258	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CS—obesity	6.29e-06	0.000245	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DGAT2—obesity	6.29e-06	0.000245	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SUCLA2—obesity	6.29e-06	0.000245	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CPS1—obesity	6.29e-06	0.000245	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LIPE—obesity	6e-06	0.000233	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MUT—obesity	6e-06	0.000233	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DGAT1—obesity	5.75e-06	0.000224	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYB5A—obesity	5.75e-06	0.000224	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACLY—obesity	5.54e-06	0.000215	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ENPP1—obesity	5.35e-06	0.000208	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALOX12—obesity	5.35e-06	0.000208	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMGCS1—obesity	5.18e-06	0.000201	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACADM—obesity	5.03e-06	0.000196	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ANGPTL4—obesity	5.03e-06	0.000196	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLIN1—obesity	5.03e-06	0.000196	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PFKFB3—obesity	5.03e-06	0.000196	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PNPLA2—obesity	5.03e-06	0.000196	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SAT1—obesity	5.03e-06	0.000196	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYTB—obesity	4.89e-06	0.00019	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—OXCT1—obesity	4.89e-06	0.00019	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACACB—obesity	4.89e-06	0.00019	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PNLIP—obesity	4.77e-06	0.000185	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SRD5A1—obesity	4.77e-06	0.000185	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SDC3—obesity	4.65e-06	0.000181	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—STS—obesity	4.55e-06	0.000177	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP26B1—obesity	4.55e-06	0.000177	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HK2—obesity	4.55e-06	0.000177	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARD—obesity	4.45e-06	0.000173	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC27A1—obesity	4.36e-06	0.00017	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GLUL—obesity	4.27e-06	0.000166	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FABP4—obesity	4.27e-06	0.000166	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HSD11B1—obesity	4.05e-06	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UCP3—obesity	4.05e-06	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UCP2—obesity	4.05e-06	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ECHS1—obesity	4.05e-06	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ADH1B—obesity	3.99e-06	0.000155	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARGC1B—obesity	3.92e-06	0.000153	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACSL1—obesity	3.92e-06	0.000153	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPAM—obesity	3.92e-06	0.000153	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PCK1—obesity	3.81e-06	0.000148	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FADS1—obesity	3.81e-06	0.000148	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HADH—obesity	3.81e-06	0.000148	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACP5—obesity	3.71e-06	0.000144	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—G6PD—obesity	3.61e-06	0.000141	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HK1—obesity	3.57e-06	0.000139	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SREBF2—obesity	3.57e-06	0.000139	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPA—obesity	3.45e-06	0.000134	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPIN1—obesity	3.37e-06	0.000131	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA5—obesity	3.3e-06	0.000129	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CLOCK—obesity	3.15e-06	0.000123	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC22A1—obesity	3.15e-06	0.000123	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SULT2A1—obesity	3.07e-06	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GLP1R—obesity	3.07e-06	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DPYD—obesity	3.02e-06	0.000118	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PRKAR2B—obesity	2.91e-06	0.000113	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DCN—obesity	2.89e-06	0.000112	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CPT1A—obesity	2.81e-06	0.000109	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NAMPT—obesity	2.75e-06	0.000107	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LIPC—obesity	2.74e-06	0.000106	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCK—obesity	2.74e-06	0.000106	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOC3—obesity	2.72e-06	0.000106	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CETP—obesity	2.64e-06	0.000103	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SDC1—obesity	2.61e-06	0.000102	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKR1C3—obesity	2.57e-06	0.0001	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SCARB1—obesity	2.53e-06	9.84e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SREBF1—obesity	2.46e-06	9.55e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GOT2—obesity	2.39e-06	9.29e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FASN—obesity	2.34e-06	9.09e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BCHE—obesity	2.33e-06	9.06e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2E1—obesity	2.25e-06	8.74e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NQO1—obesity	2.22e-06	8.64e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC2A4—obesity	2.13e-06	8.28e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCG—obesity	2.13e-06	8.28e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYCS—obesity	2.1e-06	8.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GGT1—obesity	2.06e-06	8.02e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GOT1—obesity	2.06e-06	8.02e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NCOA1—obesity	2.03e-06	7.9e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—STK11—obesity	2e-06	7.79e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP19A1—obesity	2e-06	7.79e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—COMT—obesity	1.86e-06	7.24e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GNB3—obesity	1.83e-06	7.14e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARGC1A—obesity	1.83e-06	7.14e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—obesity	1.83e-06	7.11e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GNAS—obesity	1.79e-06	6.95e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOB—obesity	1.75e-06	6.81e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPL—obesity	1.67e-06	6.5e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX1—obesity	1.63e-06	6.34e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CD36—obesity	1.59e-06	6.18e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MTHFR—obesity	1.5e-06	5.85e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARA—obesity	1.48e-06	5.74e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AGT—obesity	1.43e-06	5.56e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOE—obesity	1.4e-06	5.45e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAV1—obesity	1.39e-06	5.4e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA1—obesity	1.38e-06	5.39e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CG—obesity	1.26e-06	4.92e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARG—obesity	1.22e-06	4.75e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—POMC—obesity	1.2e-06	4.68e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—INS—obesity	1.2e-06	4.65e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CD—obesity	1.11e-06	4.32e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALB—obesity	1.1e-06	4.27e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3R1—obesity	1.05e-06	4.08e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NOS3—obesity	1.05e-06	4.08e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CB—obesity	9.68e-07	3.77e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—obesity	9.59e-07	3.73e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CA—obesity	5.9e-07	2.3e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKT1—obesity	4.82e-07	1.88e-05	CbGpPWpGaD
